查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
ATP 檢測的全球市場-2022-2029
市場調查報告書
商品編碼
1129274

ATP 檢測的全球市場-2022-2029

Global ATP assays Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

預計各行業越來越多地採用快速 ATP 生物發光測定法將成為預測期內的驅動力。

快速 ATP 生物發光測試廣泛用於許多最終用途行業，包括製藥、生物技術、醫療保健以及食品和飲料行業。這些測試可準確測量食品和藥品樣品中的微生物數量，□□並評估各種表面上的污漬和污染物數量。此外，對快速 ATP 生物發光檢測的需求受到醫院感染率上升、先進去污技術採用增加、公共衛生和衛生工作增加以及對水和廢水處理廠檢測微生物污染的需求增加的推動。通過越來越多地使用 ATP 檢測。因此，從上述陳述來看，預計市場將在預測期內提振。

限制

設備的高成本和無法區分細胞外和細胞內 ATP 被認為是在預測期內阻礙市場的因素之一。

行業分析

ATP 檢測市場根據搬運工五力、供應鍊和價格分析等各種行業因素對市場進行深入分析。

COVID-19 影響分析

COVID-19 大流行正在對市場產生積極影響。由於大流行性疫苗的生產，細胞培養基在 COVID-19 研究中的使用增加。製藥公司、生物技術公司、研究機構和學術機構正在開展重要的疫苗相關研究，但基本不受影響。對於 COVID-19，幾種疫苗和抗病毒藥物已經獲得批准或正在生產中。這增加了對細胞分析產品的需求，例如用於製藥公司和醫療環境中表面和儀器淨化的 ATP 分析。此外，藥物和疫苗開發中對基於細胞的檢測的需求不斷增加，批准的藥物和生物製品數量，整體臨床試驗，以及由於製藥公司研發支出增加導致生物製品市場的增長等。我們預計將增加用法。因此，從以上陳述來看，市場有望提振預測期。

本報告提供超過 45 個市場數據表、超過 40 個圖表和 180 頁信息。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 快速 ATP 生物發光檢測已在各個行業採用，預計將在預測期內推動市場發展。
    • 限制因素
      • 設備的高成本預計將成為預測期內的一個障礙。
    • 市場機會
    • 影響分析

第五章行業分析

  • 波特的五種力量
  • 未滿足的需求
  • 供應鏈
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 發布前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 消耗品/配件
    • 試劑和試劑盒
    • 微孔板
    • 其他
  • 測量設備
      • 光度計
      • 分光光度計

第 8 章. 按應用程序

  • 污染檢查
  • 疾病檢測
  • 藥物發現和藥物開發
  • 其他

第 9 章，最終用戶

  • 製藥和生物技術公司
  • 飲料行業
  • 醫院和診斷機構
  • 學術和研究機構
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 12 章公司簡介

  • Thermo Fisher Scientific, Inc.
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Promega Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Abcam plc
  • Lonza Group
  • 3M
  • Xylem
  • Geno Technology Inc.

第 13 章 ATP 檢測的全球市場-DataM

簡介目錄
Product Code: DMBT5850

Market Overview

ATP Assays Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

ATP or Adenosine triphosphate is an organic substance that is the main energy source in all living things and powers various biological functions like nerve impulse transmission, muscular contraction, and chemical synthesis. Since the presence of ATP influences a cell's viability, the concentration of ATP directly correlates with the number of active cells. Cell viability is measured, and bacteria and other microbes are found using ATP assays, which are ATP detection techniques. The fluorescent, bioluminescent, and colorimetric ATP tests are the most widely used ATP assays. Due to its better practicality, increased sensitivity, homogeneous technique, and quick results, bioluminescent ATP assays are the most optimal. These tests are widespread in diagnostic labs, hospitals, and research labs. They are also widely used in the food and beverage industry to determine the cleanliness and safety of food or liquid samples. As they are better at identifying the overall microbial content of samples, ATP assays are now increasingly favored over traditional culture-based diagnostics. A few benefits of ATP tests include quick testing and monitoring, increased sensitivity, and quicker, more precise results.

Market Dynamics

The rising adoption of Rapid ATP bioluminescence assays in various industries is expected to drive in the forecast period.

Rapid ATP bioluminescence tests are widely used across many end-use industries, including the pharmaceutical, biotechnology, healthcare, and food & beverage industries. These tests accurately determine the number of microorganisms in food and medicine samples and evaluate the amount of dirt or contaminants on different surfaces. Moreover, the demand for quick ATP bioluminescence assays has been driven by the rising rate of hospital-acquired infections, increasing adoption of advanced sanitization techniques, increasing public health & hygiene initiatives, and growing use of ATP assays in water and wastewater treatment plants to detect microbial contamination. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of the instruments, the inability to differentiate between extracellular and intracellular ATP are some of the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The ATP assays market provides in-depth analysis of the market based on various industry factors such as porter five forces, supply chain, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has positively impacted the market. Cell culture media use for COVID-19 research has increased due to the manufacturing of vaccines during pandemics. Pharmaceutical and biotechnology firms, research institutes, and university institutions conduct critical vaccine-related research with largely unaffected operations and output. For COVID-19, several vaccines or antiviral medications have already received approval or are being created. This has raised the demand for cell assay products like ATP assays used in pharmaceutical firms and medical settings to decontaminate surfaces and equipment. Moreover, the increased demand for cell-based assays in developing pharmaceuticals and vaccines, the number of approved medications and biologics, overall clinical trials, and the expanding biologics market with the growth in pharma R&D spending all point to an expected increase in the usage of ATP assays. Thus, from the above statements, the market is expected to boost the forecast period.

Segment Analysis

Consumables & Accessories segment is expected to hold the largest market share in ATP assays market.

The consumables & accessories segment accounted for the largest market share in 2021. The segment is sub-segmented into reagents & kits, microplates, and other consumables & accessories. Moreover, the segment is benefited from the widespread use of ATP assays in research facilities to assess cell viability, the rise in drug discovery brought on by the prevalence of chronic diseases that necessitate tumor testing and cell proliferation (in cancer), and the regular expenditure of funds by pharmaceutical and biotechnology firms on consumables. Therefore, it has increased the adoption of the ATP assays consumables & accessories.

Geographical Analysis

North America region holds the largest market share in the global ATP assays market

In 2021, the North American ATP assays accounted for the highest revenue share in the global market. The increasing prevalence of chronic diseases like cancer, rising cases of coronavirus in the region, presence of large pharmaceutical & biotechnology industries, rising demand for cell-based assays in research and rising funding for drug development by the marker players are the factors the market is expected to boost in the forecast period. For instance, according to the American Cancer Society, In 2020, an estimated 1.8 million new cancer cases and 606,520 cancer deaths in the United States will be diagnosed. In contrast, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Moreover, With a combined expenditure of USD 44.2 million (EUR 40 million) at its manufacturing plants in Danvers, Massachusetts, and Jaffrey, New Hampshire, Merck expanded its manufacturing footprint in 2020. These websites offer vital products to clients creating life-saving medications, such as COVID-19 vaccinations, as well as goods and services for the production of biopharmaceuticals. Therefore, it has increased the demand for the ATP assays, and thus the North American region accounted for the largest market share.

Competitive Landscape

Major key players in the ATP assays market are Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, 3M, Xylem, Geno Technology Inc.

Thermo Fisher Scientific, Inc.:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and based in Waltham, Massachusetts. The company offers worldwide life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Product Portfolio:

Invitrogen ATP Determination Kit: Molecular Probes ATP Determination Kit offers a convenient bioluminescence assay for quantitatively determining ATP with recombinant firefly luciferase and its substrate D-luciferin. This sensitivity has led to numerous applications for detecting ATP production in various enzymatic reactions, including ATPase and NADPH oxidase, as well as for detecting low-level bacterial contamination in samples such as blood, milk, urine, soil and sludge. The luciferin-luciferase bioluminescence assay has also been used successfully to study the effects of antibiotics on bacterial populations, to determine cell proliferation and cytotoxicity in both bacterial and mammalian cells, and to distinguish cytostatic versus the cytocidal potential of anticancer drugs on malignant cell growth.

The global ATP assays market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising adoption of Rapid ATP bioluminescence assays in various industries is expected to drive in the forecast period.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of the instruments is expected to get hampered in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Consumables & Accessories
      • 7.2.1.1. Reagents & Kits
      • 7.2.1.2. Microplates
      • 7.2.1.3. Others
      • 7.2.1.3.1. Introduction
      • 7.2.1.3.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Instruments
      • 7.3.1.1. Luminometers
      • 7.3.1.2. Spectrophotometers

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Contamination Testing*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Disease Testing
  • 8.4. Drug Discovery and Development
  • 8.5. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Pharmaceutical & Biotechnology companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Food and Beverage Industry
  • 9.4. Hospitals and Diagnostic Laboratories
  • 9.5. Academic and Research Institutions
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Thermo Fisher Scientific, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Promega Corporation
  • 12.3. Merck KGaA
  • 12.4. PerkinElmer, Inc.
  • 12.5. Agilent Technologies, Inc.
  • 12.6. Abcam plc
  • 12.7. Lonza Group
  • 12.8. 3M
  • 12.9. Xylem
  • 12.10. Geno Technology Inc.

LIST NOT EXHAUSTIVE

13. Global ATP assays Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us